July 26, 2014 11:47 AM ET


Company Overview of Nuvelo Inc.

Company Overview

As of January 27, 2009, Nuvelo Inc. was acquired by ARCA biopharma, Inc. in a reverse merger transaction. Nuvelo, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel drugs for acute cardiovascular disease, cancer, and other debilitating medical conditions in the United States. Its development pipeline includes alfimeprase, a recombinant direct-acting fibrinolytic that is in Phase II clinical trial for the treatment of thrombotic-related disorders, such as acute ischemic stroke and catheter occlusion; NU172, a thrombin inhibiting aptamer, is in Phase I development for use as a short-acting anticoagulant during medical or surgical procedures...

201 Industrial Road

Suite 310

San Carlos, CA 94070-6211

United States

Founded in 1991

81 Employees





Key Executives for Nuvelo Inc.

Nuvelo Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Targeted Diagnostics & Therapeutics, Inc. United States
Madison Vaccines, Inc. United States
Boston Probes, Inc. United States
Carigent Therapeutics, Inc. United States
BioWa, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nuvelo Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.